United States Rivaroxaban Market Report 2017

November 2017 | 97 pages | ID: UF39606EB6DEN
QYResearch

Abstracts

In this report, the United States Rivaroxaban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Rivaroxaban in these regions, from 2012 to 2022 (forecast).

United States Rivaroxaban market competition by top manufacturers/players, with Rivaroxaban sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer
• J&J

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 2.5 mg
• 10 mg
• 15 mg
• 20 mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Rivaroxaban for each application, including

• Acute coronary syndrome (ACS)
• Venous thromboembolism (VTE)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Rivaroxaban Market Report 2017

1 RIVAROXABAN OVERVIEW

1.1 Product Overview and Scope of Rivaroxaban
1.2 Classification of Rivaroxaban by Product Category
  1.2.1 United States Rivaroxaban Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Rivaroxaban Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 2.5 mg
  1.2.4 10 mg
  1.2.5 15 mg
  1.2.6 20 mg
1.3 United States Rivaroxaban Market by Application/End Users
  1.3.1 United States Rivaroxaban Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Acute coronary syndrome (ACS)
  1.3.3 Venous thromboembolism (VTE)
1.4 United States Rivaroxaban Market by Region
  1.4.1 United States Rivaroxaban Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Rivaroxaban Status and Prospect (2012-2022)
  1.4.3 Southwest Rivaroxaban Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Rivaroxaban Status and Prospect (2012-2022)
  1.4.5 New England Rivaroxaban Status and Prospect (2012-2022)
  1.4.6 The South Rivaroxaban Status and Prospect (2012-2022)
  1.4.7 The Midwest Rivaroxaban Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Rivaroxaban (2012-2022)
  1.5.1 United States Rivaroxaban Sales and Growth Rate (2012-2022)
  1.5.2 United States Rivaroxaban Revenue and Growth Rate (2012-2022)

2 UNITED STATES RIVAROXABAN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Rivaroxaban Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Rivaroxaban Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Rivaroxaban Average Price by Players/Suppliers (2012-2017)
2.4 United States Rivaroxaban Market Competitive Situation and Trends
  2.4.1 United States Rivaroxaban Market Concentration Rate
  2.4.2 United States Rivaroxaban Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Rivaroxaban Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RIVAROXABAN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Rivaroxaban Sales and Market Share by Region (2012-2017)
3.2 United States Rivaroxaban Revenue and Market Share by Region (2012-2017)
3.3 United States Rivaroxaban Price by Region (2012-2017)

4 UNITED STATES RIVAROXABAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Rivaroxaban Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Rivaroxaban Revenue and Market Share by Type (2012-2017)
4.3 United States Rivaroxaban Price by Type (2012-2017)
4.4 United States Rivaroxaban Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RIVAROXABAN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Rivaroxaban Sales and Market Share by Application (2012-2017)
5.2 United States Rivaroxaban Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RIVAROXABAN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rivaroxaban Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 J&J
  6.2.2 Rivaroxaban Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview

7 RIVAROXABAN MANUFACTURING COST ANALYSIS

7.1 Rivaroxaban Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rivaroxaban

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rivaroxaban Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RIVAROXABAN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Rivaroxaban Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Rivaroxaban Sales Volume Forecast by Type (2017-2022)
11.3 United States Rivaroxaban Sales Volume Forecast by Application (2017-2022)
11.4 United States Rivaroxaban Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rivaroxaban
Figure United States Rivaroxaban Market Size (K Units) by Type (2012-2022)
Figure United States Rivaroxaban Sales Volume Market Share by Type (Product Category) in 2016
Figure 2.5 mg Product Picture
Figure 10 mg Product Picture
Figure 15 mg Product Picture
Figure 20 mg Product Picture
Figure United States Rivaroxaban Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Rivaroxaban by Application in 2016
Figure Acute coronary syndrome (ACS) Examples
Table Key Downstream Customer in Acute coronary syndrome (ACS)
Figure Venous thromboembolism (VTE) Examples
Table Key Downstream Customer in Venous thromboembolism (VTE)
Figure United States Rivaroxaban Market Size (Million USD) by Region (2012-2022)
Figure The West Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Rivaroxaban Sales (K Units) and Growth Rate (2012-2022)
Figure United States Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Rivaroxaban Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Rivaroxaban Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Rivaroxaban Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Rivaroxaban Sales Share by Players/Suppliers
Figure 2017 United States Rivaroxaban Sales Share by Players/Suppliers
Figure United States Rivaroxaban Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Rivaroxaban Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Rivaroxaban Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Rivaroxaban Revenue Share by Players/Suppliers
Figure 2017 United States Rivaroxaban Revenue Share by Players/Suppliers
Table United States Market Rivaroxaban Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Rivaroxaban Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Rivaroxaban Market Share of Top 3 Players/Suppliers
Figure United States Rivaroxaban Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Rivaroxaban Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Rivaroxaban Product Category
Table United States Rivaroxaban Sales (K Units) by Region (2012-2017)
Table United States Rivaroxaban Sales Share by Region (2012-2017)
Figure United States Rivaroxaban Sales Share by Region (2012-2017)
Figure United States Rivaroxaban Sales Market Share by Region in 2016
Table United States Rivaroxaban Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Rivaroxaban Revenue Share by Region (2012-2017)
Figure United States Rivaroxaban Revenue Market Share by Region (2012-2017)
Figure United States Rivaroxaban Revenue Market Share by Region in 2016
Table United States Rivaroxaban Price (USD/Unit) by Region (2012-2017)
Table United States Rivaroxaban Sales (K Units) by Type (2012-2017)
Table United States Rivaroxaban Sales Share by Type (2012-2017)
Figure United States Rivaroxaban Sales Share by Type (2012-2017)
Figure United States Rivaroxaban Sales Market Share by Type in 2016
Table United States Rivaroxaban Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Rivaroxaban Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Rivaroxaban by Type (2012-2017)
Figure Revenue Market Share of Rivaroxaban by Type in 2016
Table United States Rivaroxaban Price (USD/Unit) by Types (2012-2017)
Figure United States Rivaroxaban Sales Growth Rate by Type (2012-2017)
Table United States Rivaroxaban Sales (K Units) by Application (2012-2017)
Table United States Rivaroxaban Sales Market Share by Application (2012-2017)
Figure United States Rivaroxaban Sales Market Share by Application (2012-2017)
Figure United States Rivaroxaban Sales Market Share by Application in 2016
Table United States Rivaroxaban Sales Growth Rate by Application (2012-2017)
Figure United States Rivaroxaban Sales Growth Rate by Application (2012-2017)
Table Bayer Basic Information List
Table Bayer Rivaroxaban Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Rivaroxaban Sales Growth Rate (2012-2017)
Figure Bayer Rivaroxaban Sales Market Share in United States (2012-2017)
Figure Bayer Rivaroxaban Revenue Market Share in United States (2012-2017)
Table J&J Basic Information List
Table J&J Rivaroxaban Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure J&J Rivaroxaban Sales Growth Rate (2012-2017)
Figure J&J Rivaroxaban Sales Market Share in United States (2012-2017)
Figure J&J Rivaroxaban Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivaroxaban
Figure Manufacturing Process Analysis of Rivaroxaban
Figure Rivaroxaban Industrial Chain Analysis
Table Raw Materials Sources of Rivaroxaban Major Players/Suppliers in 2016
Table Major Buyers of Rivaroxaban
Table Distributors/Traders List
Figure United States Rivaroxaban Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Rivaroxaban Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Rivaroxaban Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Rivaroxaban Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Rivaroxaban Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Rivaroxaban Sales Volume (K Units) Forecast by Type in 2022
Table United States Rivaroxaban Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Rivaroxaban Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Rivaroxaban Sales Volume (K Units) Forecast by Application in 2022
Table United States Rivaroxaban Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Rivaroxaban Sales Volume Share Forecast by Region (2017-2022)
Figure United States Rivaroxaban Sales Volume Share Forecast by Region (2017-2022)
Figure United States Rivaroxaban Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources